Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$3.55M |
| 2 |
RTX Corp
RTX
|
+$3.19M |
| 3 |
JPMorgan Chase
JPM
|
+$2.99M |
| 4 |
GE Aerospace
GE
|
+$2.4M |
| 5 |
Plains All American Pipeline
PAA
|
+$1.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$2.87M |
| 2 |
Amgen
AMGN
|
+$1.8M |
| 3 |
Amazon
AMZN
|
+$89.4K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$54.1K |
| 5 |
Biogen
BIIB
|
+$40.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.24% |
| 2 | Industrials | 12.25% |
| 3 | Consumer Discretionary | 11.61% |
| 4 | Financials | 10.84% |
| 5 | Consumer Staples | 10.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Verizon
VZ
$205B
| $3.05M | 2.22% |
55,398
+30
| +0.1% | +$1.69K |
|
27
Nike
NKE
$60.5B
| $3.03M | 2.21% |
30,882
-56
| -0.2% | -$5.17K |
|
28
Merck
MRK
$376B
| $2.98M | 2.17% |
40,367
-4
| -0% | -$301 |
|
|
29
JPMorgan Chase
JPM
$935B
| $2.96M | 2.16% |
+31,500
| New | +$2.99M |
|
30
Pfizer
PFE
$160B
| $2.94M | 2.14% |
94,592
+7
| +0% | +$238 |
|
31
Meta Platforms (Facebook)
META
$1.4T
| $2.83M | 2.06% |
12,455
-136
| -1% | -$28.4K |
|
|
32
GE Aerospace
GE
$361B
| $2.54M | 1.85% |
74,663
+71,027
| +1,953% | +$2.4M |
|
|
JWN
33
DELISTED
Nordstrom
JWN
| $2.45M | 1.78% |
157,974
+10,188
| +7% | +$179K |
|
34
Emerson Electric
EMR
$87.7B
| $2.03M | 1.48% |
32,720
+37
| +0.1% | +$2.1K |
|
35
iShares MSCI EAFE ETF
EFA
$80B
| $1.01M | 0.73% |
16,545
-254
| -2% | -$14.7K |
|
36
Medtronic
MDT
$119B
| $290K | 0.21% |
3,161
+97
| +3% | +$9.3K |
|
37
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $200K | 0.15% |
+648
| New | +$190K |
|
38
iShares Russell Mid-Cap ETF
IWR
$57.7B
| $137K | 0.1% |
2,547
+13
| +0.5% | +$652 |
|
|
39
Amgen
AMGN
$238B
| – | – |
-8,888
| Closed | -$1.8M |
|
|
RTN
40
DELISTED
Raytheon Company
RTN
| – | – |
-21,900
| Closed | -$2.87M |
|
Similar funds
Mark Hillman's Q2 2020 Portfolio in Review
As of Q2 2020, Mark Hillman held 40 positions worth $137M, up 31% from $104M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Mark Hillman deployed $16M of net new capital in Q2 2020, opening 4 new positions and adding to 22 existing holdings. Its largest new stake was Boeing: 23,115 shares worth $4.24M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Amazon, an estimated $89.4K trimmed.
- Mark Hillman's largest Q2 2020 buy was Boeing: 23,115 shares worth $4.24M.
- Mark Hillman added most to GE Aerospace in Q2 2020, an estimated $2.4M increase.
- Mark Hillman's biggest Q2 2020 reduction was Amazon, cutting an estimated $89.4K.
- Mark Hillman fully exited Raytheon Company in Q2 2020, selling an estimated $2.87M.
- Mark Hillman's ten largest holdings make up 39% of its $137M portfolio in Q2 2020.
- Mark Hillman opened 4 new positions and closed 2 in Q2 2020.
- Mark Hillman's portfolio value rose 31% quarter-over-quarter to $137M.
Based on Hillman Capital Management's 13F filing for Q2 2020, filed 4 Aug 2020.